Article: United Research Laboratories/Mutual Pharmaceutical Company Announce ANDA Filing for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg.

PHILADELPHIA, Aug. 18 /PRNewswire/ -- United Research Laboratories and Mutual Pharmaceutical Company today announce that Mutual has filed an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration (FDA), seeking approval to market Mutual's guaifenesin extended-release tablets, 600 mg and 1200 mg. Guaifenesin extended-release tablets are currently marketed over-the-counter by Adams Respiratory Therapeutics under the brand name Mucinex(R). According to Adams, Mucinex(R) is one of the most widely recommended OTC products to treat chest congestion and related coughs.

On August 9, 2006, FDA determined that Mutual's guaifenesin extended-release ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!